ARTICLE | Company News
Asuragen cancer news
April 7, 2008 7:00 AM UTC
Asuragen spun out Mirna Therapeutics Inc. to develop and commercialize microRNA (miRNA) cancer therapeutics. Asuragen is transferring its IP covering miRNA therapeutics to Mirna, including exclusive ...